153 related articles for article (PubMed ID: 27449095)
1. Adjuvant treatment may benefit patients with high-risk upper rectal cancer: A nomogram and recursive partitioning analysis of 547 patients.
Wang X; Jin J; Yang Y; Liu WY; Ren H; Feng YR; Xiao Q; Li N; Deng L; Fang H; Jing H; Lu NN; Tang Y; Wang JY; Wang SL; Wang WH; Song YW; Liu YP; Li YX
Oncotarget; 2016 Oct; 7(40):66160-66169. PubMed ID: 27449095
[TBL] [Abstract][Full Text] [Related]
2. The number of cycles of adjuvant chemotherapy in stage III and high-risk stage II rectal cancer: a nomogram and recursive partitioning analysis.
Chen WW; Wang WL; Dong HM; Wang G; Li XK; Li GD; Chen WH; Chen J; Bai SX
World J Surg Oncol; 2022 Apr; 20(1):119. PubMed ID: 35413852
[TBL] [Abstract][Full Text] [Related]
3. Possible contribution of IMRT in postoperative radiochemotherapy for rectal cancer: analysis on 1798 patients by prediction model.
Liu WY; Dinapoli N; Wang X; Meldolesi E; Gambacorta MA; Chiloiro G; Ren H; Fang H; Lu NN; Tang Y; Deng L; Wang JY; Jing H; Xiao Q; Feng YR; Li YX; Wang SL; Song YW; Liu YP; Wang WH; Valentini V; Jin J
Oncotarget; 2016 Jul; 7(29):46536-46544. PubMed ID: 27340785
[TBL] [Abstract][Full Text] [Related]
4. Predicting prognosis in resected esophageal squamous cell carcinoma using a clinical nomogram and recursive partitioning analysis.
Zheng Y; Fu S; He T; Yan Q; Di W; Wang J
Eur J Surg Oncol; 2018 Aug; 44(8):1199-1204. PubMed ID: 29784506
[TBL] [Abstract][Full Text] [Related]
5. A nomogram to predict distant metastasis after neoadjuvant chemoradiotherapy and radical surgery in patients with locally advanced rectal cancer.
Sun Y; Lin H; Lu X; Huang Y; Xu Z; Huang S; Wang X; Chi P
J Surg Oncol; 2017 Mar; 115(4):462-469. PubMed ID: 28105657
[TBL] [Abstract][Full Text] [Related]
6. A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
Newton AD; Li J; Jeganathan AN; Mahmoud NN; Epstein AJ; Paulson EC
Dis Colon Rectum; 2016 Aug; 59(8):710-7. PubMed ID: 27384088
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of neoadjuvant rectal score in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and construction of a prediction model.
Sun Y; Zhang Y; Wu X; Lin H; Lu X; Huang Y; Xu Z; Huang S; Wang X; Chi P
J Surg Oncol; 2018 Mar; 117(4):737-744. PubMed ID: 29228455
[TBL] [Abstract][Full Text] [Related]
8. Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center.
Zhou J; Qiu H; Lin G; Xiao Y; Wu B; Wu W; Sun X; Lu J; Zhang G; Xu L; Liu Y
Int J Colorectal Dis; 2016 Jun; 31(6):1163-8. PubMed ID: 27044403
[TBL] [Abstract][Full Text] [Related]
9. Nomogram basing pre-treatment parameters predicting early response for locally advanced rectal cancer with neoadjuvant chemotherapy alone: a subgroup efficacy analysis of FOWARC study.
Zhang J; Cai Y; Hu H; Lan P; Wang L; Huang M; Kang L; Wu X; Wang H; Ling J; Xiao J; Wang J; Deng Y
Oncotarget; 2016 Jan; 7(4):5053-62. PubMed ID: 26646794
[TBL] [Abstract][Full Text] [Related]
10. A nomogram for predicting 10-year cancer specific survival in patients with pathological T3N0M0 rectal cancer.
Liu S; Yang S; Yu H; Luo H; Chen G; Gao Y; Sun R; Xiao W
Front Med (Lausanne); 2022; 9():977652. PubMed ID: 36072948
[TBL] [Abstract][Full Text] [Related]
11. Nomograms to predict survival after colorectal cancer resection without preoperative therapy.
Zhang ZY; Luo QF; Yin XW; Dai ZL; Basnet S; Ge HY
BMC Cancer; 2016 Aug; 16(1):658. PubMed ID: 27553083
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
13. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials.
Valentini V; van Stiphout RG; Lammering G; Gambacorta MA; Barba MC; Bebenek M; Bonnetain F; Bosset JF; Bujko K; Cionini L; Gerard JP; Rödel C; Sainato A; Sauer R; Minsky BD; Collette L; Lambin P
J Clin Oncol; 2011 Aug; 29(23):3163-72. PubMed ID: 21747092
[TBL] [Abstract][Full Text] [Related]
14. The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy.
Zhang LN; Xiao W; OuYang PY; You K; Zeng ZF; Ding PR; Pan ZZ; Xu RH; Gao YH
Tumour Biol; 2015 Sep; 36(10):8213-9. PubMed ID: 25994571
[TBL] [Abstract][Full Text] [Related]
15. Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision.
Lee JH; Jang HS; Kim JG; Cho HM; Shim BY; Oh ST; Yoon SC; Kim YS; Choi BO; Kim SH
Ann Surg Oncol; 2012 Apr; 19(4):1213-21. PubMed ID: 21935746
[TBL] [Abstract][Full Text] [Related]
16. Nomogram to predict ypN status after chemoradiation in patients with locally advanced rectal cancer.
Jwa E; Kim JH; Han S; Park JH; Lim SB; Kim JC; Hong YS; Kim TW; Yu CS
Br J Cancer; 2014 Jul; 111(2):249-54. PubMed ID: 24967873
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
[TBL] [Abstract][Full Text] [Related]
18. Impact of adjuvant chemotherapy after neoadjuvant radio- or radiochemotherapy for patients with locally advanced rectal cancer.
Lichthardt S; Zenorini L; Wagner J; Baur J; Kerscher A; Matthes N; Kastner C; Pelz J; Kunzmann V; Germer CT; Wiegering A
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2363-2373. PubMed ID: 28756493
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom?
De Stefano A; Moretto R; Bucci L; Pepe S; Romano FJ; Cella AC; Attademo L; Rosanova M; De Falco S; Fiore G; Raimondo L; De Placido S; Carlomagno C
Clin Colorectal Cancer; 2014 Sep; 13(3):185-91. PubMed ID: 25080847
[TBL] [Abstract][Full Text] [Related]
20. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]